Our findings underscore the critical role of pyroptosis in psoriasis pathogenesis and demonstrate that targeting CASP1 and CASP5 through CRISPR-Cas9 gene editing can effectively alleviate disease symptoms and reduce inflammation in the IMQ-induced mouse model. The gene discussed is CASP1; the disease is psoriasis.